Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Asia Pacific Multivitamin Market 2016 & Market Forecasts to 2022 - Research and Markets

Research and Markets
Posted on: 27 Sep 16

Research and Markets has announced the addition of the "Asia Pacific Multivitamin Market 2016" report to their offering.

A comprehensive analysis of the Asia Pacific Multivitamin Market including market sizing, market share by competitor, drivers, restraints, consumer trends, distribution by revenue, sales by end user and market forecasts to 2022.

Multivitamins: Includes multivitamins (combination of essential vitamins and minerals), to provide a convenient way to take a variety of supplemental nutrients from a single product to prevent deficiencies, or boost nutrient intake, above typical dietary levels.

Exclude combinations of a multivitamin with other dietary supplements, such as probiotics or omega fatty acids, tracked in the category of combination dietary supplements.

Sales Channels

  • Retail
  • Grocery Retailers
  • Non-Grocery Retailers
  • Home shopping
  • E-commerce
  • Direct Sales

Key Topics Covered:

I. Definition, Methodology & Global Overview

a. Key Takeaways

b. Target Markets

c. Consumer Trends

d. Strategic Recommendations

II. The Future of Multivitamins

a. Customization

b. Vitamin Enhancement

c. Organizational Initiatives

III. Country Analysis

1. Consumer Trends & Market Trends

2. Market Drivers, Restraints, Product Claims & Marketing

3. Market Shares by Company

4. Market Forecasts by Revenue (2015-2022)

5. Distribution by Revenue

6. Sales of Multivitamins by End User

a. China

b. Japan

c. South Korea

d. Taiwan

e. Thailand

f. India

g. Malaysia

h. Vietnam

IV. Company Profiles

V. Definitions, Citations

Companies Mentioned

  • Abtei OP Pharma GmbH
  • Amway
  • Bayer AG
  • Blackmores Ltd
  • Boehringer Ingelheim GmbH
  • Ching Hwa Biotechnology Co., Ltd.
  • Cosway (M), Sdn. Bhd.
  • Dirk Rossmann GmbH
  • Dr. Willmar Schwabe GmbH & Co. KG
  • Eisai Co., Ltd.
  • GNC Holdings, Inc.
  • Guangzhou By-Health Biological Engineering Co Ltd
  • Herbalife Ltd.
  • ICA Biotechnological
  • Ildong Pharmaceuticals Co., Ltd.
  • Jeunesse Global
  • Merck KGaA
  • NBTY, Inc.
  • Nu Skin Enterprises, Inc.
  • OTCPharm
  • Pfizer Inc.
  • Sinphar Pharmaceutical Co., Ltd.
  • Takeda Pharmaceutical Company Ltd
  • Tradewind Asia Ltd
  • Unipharm, Inc.

For more information about this report visit

View source version on

Business Wire

Last updated on: 27/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.